Login / Signup

Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer.

Akira YamagataToshihide YokoyamaYasushi FukudaTadashi Ishida
Published in: Cancer chemotherapy and pharmacology (2021)
The DAD pattern may predict short-term adverse prognosis for ICI-ILD. Once ICI-ILD is overcome, severity grade is not associated with prognosis. Even if initial immunotherapy proves effective, ICI rechallenge requires careful consideration.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • ms ms
  • emergency department